
### [MONDO:0016327](http://purl.obolibrary.org/obo/MONDO_0016327)
**Label:** mitochondrial disease with hypertrophic cardiomyopathy

**Subclasses:** [MONDO:0017336](http://purl.obolibrary.org/obo/MONDO_0017336) (fatal infantile hypertrophic cardiomyopathy due to mitochondrial complex i deficiency), [MONDO:0013840](http://purl.obolibrary.org/obo/MONDO_0013840) (encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome), [MONDO:0014175](http://purl.obolibrary.org/obo/MONDO_0014175) (mitochondrial DNA depletion syndrome 12), [MONDO:0008132](http://purl.obolibrary.org/obo/MONDO_0008132) (optic atrophy with demyelinating disease of CNS), [MONDO:0010790](http://purl.obolibrary.org/obo/MONDO_0010790) (MERRF syndrome), [MONDO:0014562](http://purl.obolibrary.org/obo/MONDO_0014562) (neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome), [MONDO:0014162](http://purl.obolibrary.org/obo/MONDO_0014162) (infantile hypertrophic cardiomyopathy due to MRPL44 deficiency), [MONDO:0015283](http://purl.obolibrary.org/obo/MONDO_0015283) (maternally-inherited cardiomyopathy and hearing loss), [MONDO:0020478](http://purl.obolibrary.org/obo/MONDO_0020478) (Leber plus disease), [MONDO:0014190](http://purl.obolibrary.org/obo/MONDO_0014190) (combined oxidative phosphorylation defect type 17), [MONDO:0008922](http://purl.obolibrary.org/obo/MONDO_0008922) (Sengers syndrome), [MONDO:0010640](http://purl.obolibrary.org/obo/MONDO_0010640) (Leber optic atrophy, susceptibility to), [MONDO:0010772](http://purl.obolibrary.org/obo/MONDO_0010772) (Leber optic atrophy and dystonia), [MONDO:0010789](http://purl.obolibrary.org/obo/MONDO_0010789) (MELAS syndrome), [MONDO:0014525](http://purl.obolibrary.org/obo/MONDO_0014525) (combined oxidative phosphorylation defect type 23), [MONDO:0013865](http://purl.obolibrary.org/obo/MONDO_0013865) (mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency), [MONDO:0017933](http://purl.obolibrary.org/obo/MONDO_0017933) (hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation), [MONDO:0010788](http://purl.obolibrary.org/obo/MONDO_0010788) (Leber hereditary optic neuropathy), 

**Corr. equiv. classes:** [Orphanet:289527](http://www.orpha.net/ORDO/Orphanet_289527), [OMIM:545000](http://purl.obolibrary.org/obo/OMIM_545000), [OMIM:615440](http://purl.obolibrary.org/obo/OMIM_615440), [OMIM:308905](http://purl.obolibrary.org/obo/OMIM_308905), [OMIM:616276](http://purl.obolibrary.org/obo/OMIM_616276), [OMIM:616198](http://purl.obolibrary.org/obo/OMIM_616198), [Orphanet:457185](http://www.orpha.net/ORDO/Orphanet_457185), [Orphanet:314637](http://www.orpha.net/ORDO/Orphanet_314637), [OMIM:614654](http://purl.obolibrary.org/obo/OMIM_614654), [OMIM:535000](http://purl.obolibrary.org/obo/OMIM_535000), [Orphanet:444013](http://www.orpha.net/ORDO/Orphanet_444013), [Orphanet:551](http://www.orpha.net/ORDO/Orphanet_551), [Orphanet:319678](http://www.orpha.net/ORDO/Orphanet_319678), [Orphanet:550](http://www.orpha.net/ORDO/Orphanet_550), [OMIM:540000](http://purl.obolibrary.org/obo/OMIM_540000), [OMIM:500001](http://purl.obolibrary.org/obo/OMIM_500001), [Orphanet:324525](http://www.orpha.net/ORDO/Orphanet_324525), [Orphanet:369913](http://www.orpha.net/ORDO/Orphanet_369913), [OMIM:615395](http://purl.obolibrary.org/obo/OMIM_615395), [Orphanet:352563](http://www.orpha.net/ORDO/Orphanet_352563), [Orphanet:99718](http://www.orpha.net/ORDO/Orphanet_99718), [OMIM:614702](http://purl.obolibrary.org/obo/OMIM_614702), [OMIM:615418](http://purl.obolibrary.org/obo/OMIM_615418), [OMIM:165200](http://purl.obolibrary.org/obo/OMIM_165200), [Orphanet:104](http://www.orpha.net/ORDO/Orphanet_104), [Orphanet:1349](http://www.orpha.net/ORDO/Orphanet_1349), [OMIM:212350](http://purl.obolibrary.org/obo/OMIM_212350), [Orphanet:1369](http://www.orpha.net/ORDO/Orphanet_1369), 

**Class expressions from DL-Learner:**

- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 39.69%
- [HP:0001627](http://purl.obolibrary.org/obo/HP_0001627) (Abnormal heart morphology) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 39.69%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 37.86%
- [HP:0001941](http://purl.obolibrary.org/obo/HP_0001941) (Acidosis) 36.18%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 36.15%
- Thing 36.14%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 36.14%
- [HP:0004360](http://purl.obolibrary.org/obo/HP_0004360) (Abnormality of acid-base homeostasis) 35.64%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 35.21%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 32.14%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 31.30%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 30.51%
- [HP:0003128](http://purl.obolibrary.org/obo/HP_0003128) (Lactic acidosis) 30.37%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 28.56%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 28.02%


